C. McKillop

发表

Treatment preferences of patients with relapsed and refractory multiple myeloma: a qualitative study

J. Parsons, Nicole R. Greenspan, L. Hicks, 2019, BMC Cancer.

Interview with Jack Schalken

C. McKillop, 2006 .

Interview with John Fitzpatrick – Combination Therapy for BPH: Is This the Way Forward?

C. McKillop, 2006 .

Interview with Chris Chapple. Overactive bladder: tackling the problem.

C. McKillop, 2006 .

Interview with Dr Richard Sylvester: Transition Cell Carcinoma of the Bladder

C. McKillop, 2007 .

Cancer patients’ experiences with immune checkpoint modulators: A qualitative study

A. Oza, Philippe Bédard, L. Siu, 2020, Cancer medicine.

Development of the Functional Assessment of Cancer Therapy–Immune Checkpoint Modulator (FACT‐ICM): A toxicity subscale to measure quality of life in patients with cancer who are treated with ICMs

Christopher T. Chan, A. Oza, D. Cella, 2020, Cancer.

Interview with Dr François Giuliano New Avenues in the Pharmacological Treatment of Premature Ejaculation

C. McKillop, 2007 .

Interview with Dr Guido Barbagli Substitution Urethroplasty: Which Tissues and Techniques are Optimal for Urethral Replacement?

C. McKillop, 2007 .

Treatment preferences of patients with relapsed and refractory multiple myeloma: a qualitative study

J. Parsons, Nicole R. Greenspan, L. Hicks, 2019, BMC Cancer.

Development of the functional assessment of cancer therapy-immune checkpoint modulator (FACT-ICM): A scale to measure quality of life in cancer patients treated with ICMs

A. Oza, D. Cella, L. Siu, 2019, Annals of Oncology.

A quantitative assessment of pyrethroid-induced paraesthesia in the guinea-pig flank model.

G. Oliver, J. Brock, C. Rhodes, 1987, Toxicology letters.